amniotic stem cells

Cell therapyexperimental

Amniotic stem cells are the mixture of stem cells that can be obtained from the amniotic fluid as well as the amniotic membrane. They can develop into various tissue types including skin, cartilage, cardiac tissue, nerves, muscle, and bone. The cells also have potential medical applications, especially in organ regeneration. — Wikipedia

Clinical trial activity

5 trials · 7 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
1

Earliest trial started Jan 1, 2014 (NCT04318600)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetTissue restoration

    tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • amniotic stem cells

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07115082Phase 1/Phase 2 (Phase 2)Oct 15, 2024Changhai Hospital
NCT04676269Early Phase 1 (Phase 1)Dec 9, 2019University of Indonesia
NCT04592640N/ASep 17, 2018Nanjing Medical University
NCT02314416Phase 4May 1, 2015Augusta University, NuTech Medical, Inc
NCT04318600Phase 1Jan 1, 2014Kunming Medical University, The First People's Hospital of Yunan Province
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Augusta UniversityAcademic/Hospital1112015
Changhai HospitalAcademic/Hospital1112024
Kunming Medical UniversityAcademic/Hospital1112014
Nanjing Medical UniversityAcademic/Hospital1112018
NuTech Medical, IncFor profit1012015
The First People's Hospital of Yunan ProvinceAcademic/Hospital1012014
University of IndonesiaAcademic/Hospital1112019
7 organizations
Page 1 / 1